DE69739856D1 - Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungen - Google Patents
Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungenInfo
- Publication number
- DE69739856D1 DE69739856D1 DE69739856T DE69739856T DE69739856D1 DE 69739856 D1 DE69739856 D1 DE 69739856D1 DE 69739856 T DE69739856 T DE 69739856T DE 69739856 T DE69739856 T DE 69739856T DE 69739856 D1 DE69739856 D1 DE 69739856D1
- Authority
- DE
- Germany
- Prior art keywords
- agonists
- growth factor
- hepatocyte growth
- receptor agonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2121596P | 1996-07-03 | 1996-07-03 | |
PCT/US1997/010688 WO1998000543A1 (en) | 1996-07-03 | 1997-06-20 | Hepatocyte growth factor receptor agonists and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69739856D1 true DE69739856D1 (de) | 2010-06-02 |
Family
ID=21803007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69739856T Expired - Lifetime DE69739856D1 (de) | 1996-07-03 | 1997-06-20 | Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US6099841A (de) |
EP (1) | EP0922102B1 (de) |
JP (1) | JP2000515735A (de) |
AT (1) | ATE465257T1 (de) |
AU (1) | AU729029B2 (de) |
CA (1) | CA2258153C (de) |
DE (1) | DE69739856D1 (de) |
DK (1) | DK0922102T3 (de) |
IL (1) | IL127558A0 (de) |
WO (1) | WO1998000543A1 (de) |
ZA (1) | ZA975851B (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
EP1053256B9 (de) * | 1998-01-26 | 2012-01-18 | Genentech, Inc. | Antikörper gegen "death receptor 4" (dr4) und deren verwendungen |
WO2001005955A2 (en) * | 1999-07-14 | 2001-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Animals comprising human hepatocellular tissue |
ATE409494T1 (de) * | 1999-10-29 | 2008-10-15 | Anges Mg Inc | Gentherapie für diabetische ischämie |
US20080241835A1 (en) * | 1999-11-01 | 2008-10-02 | Genentech, Inc. | Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
JP4993834B2 (ja) * | 2000-06-29 | 2012-08-08 | ノース ショア−ロング アイランド ジューイッシュ ヘルス システム | 細胞増殖および血管形成の調節物質、その使用方法および特定方法 |
CA2472383A1 (en) * | 2001-12-27 | 2003-07-17 | Van Andel Research Institute | Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
US20050069549A1 (en) | 2002-01-14 | 2005-03-31 | William Herman | Targeted ligands |
US9701754B1 (en) | 2002-10-23 | 2017-07-11 | City Of Hope | Covalent disulfide-linked diabodies and uses thereof |
MXPA05008521A (es) * | 2003-02-13 | 2005-10-20 | Pharmacia Corp | Anticuerpos a c-met para el tratamiento de canceres. |
US7407660B2 (en) * | 2003-04-16 | 2008-08-05 | Genentech, Inc. | Methods and compositions for selective modulation of vascularization |
US20040208876A1 (en) * | 2003-04-18 | 2004-10-21 | Kim Kyung Jin | Monoclonal antibodies to hepatocyte growth factor |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
ITMI20031127A1 (it) * | 2003-06-05 | 2004-12-06 | Uni Degli Studi Del Piemont E Orientale Am | Anticorpi anti-hgf-r e loro uso |
HN2004000285A (es) | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
EP2385069A3 (de) | 2003-11-12 | 2012-05-30 | Biogen Idec MA Inc. | Neonataler Fc-Rezeptor (FcRn)-bindende Polypeptidvarianten, dimere Fc-Bindungsproteine und damit in Zusammenhang stehende Verfahren |
US20060069019A1 (en) * | 2004-05-06 | 2006-03-30 | Genentech, Inc. | Crystal structure of the complex of hepatocyte growth factor beta chain with Met receptor and methods of use |
US20060003931A1 (en) * | 2004-05-06 | 2006-01-05 | Genentech, Inc. | Crystal structure of the hepatocyte growth factor and methods of use |
ATE475099T1 (de) * | 2004-10-20 | 2010-08-15 | Peas Inst Ab | Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) |
KR20070100346A (ko) | 2005-01-05 | 2007-10-10 | 바이오겐 아이덱 엠에이 인코포레이티드 | 크립토 결합 분자 |
EP1852124A4 (de) * | 2005-01-24 | 2009-08-12 | Kringle Pharma Inc | Fibrose-hemmer für ein implantiertes organ |
EP1867339A4 (de) * | 2005-03-02 | 2010-05-26 | Mitsubishi Tanabe Pharma Corp | Antivirales mittel |
ES2539790T3 (es) * | 2005-03-25 | 2015-07-06 | Genentech, Inc. | Métodos y composiciones para modular c-met hiperestabilizado |
US20060263808A1 (en) * | 2005-03-25 | 2006-11-23 | Genentech, Inc. | C-met mutations in lung cancer |
EP1863519B1 (de) | 2005-03-31 | 2013-09-25 | The General Hospital Corporation | Modulation von hgf/hgfr-aktivität zur behandlung von lymphödem |
JP2008545753A (ja) * | 2005-06-02 | 2008-12-18 | ギャラクシー バイオテック, エルエルシー | 抗体で脳腫瘍を処置する方法 |
JP2009531324A (ja) | 2006-03-20 | 2009-09-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌標的化のための操作された抗前立腺幹細胞抗原(psca)抗体 |
US8133867B2 (en) | 2006-03-20 | 2012-03-13 | Seikagaku Corporation | Method for treating rheumatoid arthritis with an antibody that binds to a hepatocyte growth factor receptor |
AR059922A1 (es) * | 2006-04-01 | 2008-05-07 | Galaxy Biotech Llc | Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos |
ATE528286T1 (de) | 2006-12-20 | 2011-10-15 | Bayer Healthcare Llc | 4-ä4-ä(ä3-tert-butyl-1-ä3-(hydroxymethyl)phenyl - 1h-pyrazol-5-ylücarbamoyl)-aminoü-3- chlorophenoxyü-n-methylpyridin-2-carboxamid als inhibitor der vegfr kinase zur behandlung von krebs |
JP6126773B2 (ja) | 2007-09-04 | 2017-05-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌のターゲッティングおよび検出のための高親和性抗前立腺幹細胞抗原(psca)抗体 |
US20110092452A1 (en) * | 2008-03-05 | 2011-04-21 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating pancreatic cancer |
CA2752510C (en) | 2009-02-17 | 2024-01-23 | Neil Bander | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
JP2013511969A (ja) | 2009-11-25 | 2013-04-11 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 確定的内胚葉細胞の肝分化のための方法 |
US8772459B2 (en) | 2009-12-02 | 2014-07-08 | Imaginab, Inc. | J591 minibodies and Cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use |
WO2012003338A1 (en) | 2010-07-01 | 2012-01-05 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
HUE044419T2 (hu) | 2010-07-09 | 2019-10-28 | Bioverativ Therapeutics Inc | Feldogozható egyetlen láncú molekulák és ezek alkalmazásával készült peptidek |
US9688773B2 (en) | 2010-11-03 | 2017-06-27 | Argen-X N.V. | C-Met antibody combinations |
US9738707B2 (en) | 2011-07-15 | 2017-08-22 | Biogen Ma Inc. | Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto |
EP2773660A2 (de) | 2011-11-03 | 2014-09-10 | Argen-X B.V. | Chimäre mensch-kamel-antigene und ihre verwendung |
BR112014016887A2 (pt) | 2012-01-10 | 2018-08-14 | Biogen Idec Inc | potencialização do transporte de moléculas terapêu-ticas através da barreira hematoencefálica |
US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
CA2899089C (en) | 2013-03-15 | 2021-10-26 | Biogen Ma Inc. | Factor ix polypeptide formulations |
WO2015056713A1 (ja) * | 2013-10-15 | 2015-04-23 | 国立大学法人東京大学 | c-Metタンパク質アゴニスト |
MA39776A (fr) | 2014-03-24 | 2017-02-01 | Hoffmann La Roche | Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf |
BR112017005202A2 (pt) | 2014-09-16 | 2017-12-12 | Symphogen As | anticorpos anti-met e composições |
RU2017127609A (ru) | 2015-02-04 | 2019-03-04 | Ф. Хоффманн-Ля Рош Аг | Антисмысловые олигомеры тау-белка и их применение |
CN115181778A (zh) | 2015-02-04 | 2022-10-14 | 百时美施贵宝公司 | 选择治疗性分子的方法 |
MX2018001566A (es) | 2015-08-07 | 2019-04-25 | Imaginab Inc | Construcciones de union a antigeno para moleculas diana. |
GB201611123D0 (en) * | 2016-06-27 | 2016-08-10 | Euremab Srl | Anti met antibodiesand uses thereof |
TWI782930B (zh) | 2016-11-16 | 2022-11-11 | 美商再生元醫藥公司 | 抗met抗體,結合met之雙特異性抗原結合分子及其使用方法 |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
IT201800000535A1 (it) | 2018-01-03 | 2019-07-03 | Procedimenti per la cura del cancro. | |
SG11202108525VA (en) | 2019-02-21 | 2021-09-29 | Regeneron Pharma | Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind met |
CA3143640A1 (en) * | 2019-07-26 | 2021-02-04 | Fei Yi | Methods and compositions for producing hepatocytes |
EP4031574A1 (de) | 2019-09-16 | 2022-07-27 | Regeneron Pharmaceuticals, Inc. | Radioaktiv markierte met-bindungsproteine für immuno-pet-bildgebung |
US20240084041A1 (en) | 2022-09-01 | 2024-03-14 | Regeneron Pharmaceuticals, Inc. | Methods of treating non-small cell lung cancer using mesenchymal epithelial transition factor (met)-targeted agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5362716A (en) * | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
US5648273A (en) * | 1989-12-27 | 1997-07-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Hepatic growth factor receptor is the MET proto-oncogene |
JP2750372B2 (ja) * | 1990-06-19 | 1998-05-13 | 敏一 中村 | 賢疾患治療剤 |
US6566098B1 (en) * | 1990-09-14 | 2003-05-20 | The United States Of America As Represented By The Department Of Health And Human Services | DNA encoding truncated hepatocyte growth factor variants |
DK0584125T3 (da) * | 1991-05-10 | 1997-09-08 | Pharmacia & Upjohn Spa | Afkortede former af hepatocyt vækstfaktor (HGF) receptor |
US5227158A (en) * | 1991-06-10 | 1993-07-13 | Genentech, Inc. | Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon |
WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
EP1997894B1 (de) * | 1992-02-06 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Biosynthetisches Bindeprotein für Tumormarker |
US5328837A (en) * | 1992-05-18 | 1994-07-12 | Genentech, Inc. | Hepatocyte growth factor protease domain variants |
US5316921A (en) * | 1992-05-18 | 1994-05-31 | Genentech, Inc. | Single-chain hepatocyte growth factor variants |
CA2134773A1 (en) * | 1992-06-04 | 1993-12-09 | Robert J. Debs | Methods and compositions for in vivo gene therapy |
DE69310525T2 (de) * | 1992-09-16 | 1997-10-02 | Genentech Inc | Schutz gegen leberschäden mit hgf |
AU5416694A (en) | 1992-10-28 | 1994-05-24 | Jorg Meyer | Metal-plastic composite, process for producing it and apparatus for carrying out the process |
ATE157100T1 (de) | 1993-06-03 | 1997-09-15 | Therapeutic Antibodies Inc | Antikoerperfragmente in therapie |
US5464815A (en) * | 1993-09-08 | 1995-11-07 | Genentech, Inc. | Inhibition of heparin-binding |
US5686292A (en) * | 1995-06-02 | 1997-11-11 | Genentech, Inc. | Hepatocyte growth factor receptor antagonist antibodies and uses thereof |
US8200624B2 (en) | 2010-07-20 | 2012-06-12 | Sybase, Inc. | Membership tracking and data eviction in mobile middleware scenarios |
-
1997
- 1997-06-20 AT AT97931275T patent/ATE465257T1/de not_active IP Right Cessation
- 1997-06-20 DK DK97931275.8T patent/DK0922102T3/da active
- 1997-06-20 CA CA002258153A patent/CA2258153C/en not_active Expired - Lifetime
- 1997-06-20 EP EP97931275A patent/EP0922102B1/de not_active Expired - Lifetime
- 1997-06-20 IL IL12755897A patent/IL127558A0/xx unknown
- 1997-06-20 WO PCT/US1997/010688 patent/WO1998000543A1/en active Application Filing
- 1997-06-20 JP JP10504193A patent/JP2000515735A/ja not_active Ceased
- 1997-06-20 DE DE69739856T patent/DE69739856D1/de not_active Expired - Lifetime
- 1997-06-20 AU AU34949/97A patent/AU729029B2/en not_active Expired
- 1997-06-27 US US08/884,669 patent/US6099841A/en not_active Expired - Lifetime
- 1997-07-01 ZA ZA975851A patent/ZA975851B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US6099841A (en) | 2000-08-08 |
JP2000515735A (ja) | 2000-11-28 |
AU729029B2 (en) | 2001-01-25 |
CA2258153C (en) | 2004-08-17 |
EP0922102B1 (de) | 2010-04-21 |
DK0922102T3 (da) | 2010-08-16 |
ATE465257T1 (de) | 2010-05-15 |
IL127558A0 (en) | 1999-10-28 |
AU3494997A (en) | 1998-01-21 |
WO1998000543A1 (en) | 1998-01-08 |
EP0922102A1 (de) | 1999-06-16 |
CA2258153A1 (en) | 1998-01-08 |
ZA975851B (en) | 1999-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69739856D1 (de) | Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungen | |
ATE517125T1 (de) | ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN | |
DE60232660D1 (de) | Humane dr4-antikörper und deren anwendungen | |
MXPA03005273A (es) | Anticuerpos producidos procarioticamente y sus usos. | |
TR200000927T2 (tr) | Prostaglandin agonistleri ve kemik bozukluklarının tedavisi | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
DK1181319T3 (da) | Kimære DR4-antistoffer og anvendelser deraf | |
BR0206985A (pt) | Anticorpos modificados e métodos de uso | |
EP1746160A3 (de) | Hepatozyt-Wachstumsfaktor-Rezeptor-Antagonisten und deren Anwendung | |
DE69838147D1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
ATE448686T1 (de) | Actriib-fusionspolypeptide und verwendungen dafür | |
ES2177316T3 (es) | Anticuerpos humanos antifacotores ix/ixa. | |
RS20100249A (en) | CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE | |
DE69120287T2 (de) | Aminosulfonylharnstoff-acat-inhibitoren | |
DE60024997D1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
DE60020970D1 (de) | Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf-erkrankungen | |
DE60024977D1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
EP1370697A4 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion und verfahren zu deren verwendung | |
ATE299739T1 (de) | Neurokinin b vorläufer aus menschlicher plazenta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |